KEGG   PATHWAY: hsa04662
Entry
hsa04662                    Pathway                                
Name
B cell receptor signaling pathway - Homo sapiens (human)
Description
B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The B cell receptor (BCR) is an integral membrane protein complex that is composed of two immunoglobulin (Ig) heavy chains, two Ig light chains and two heterodimers of Ig-alpha and Ig-beta. After BCR ligation by antigen, three main protein tyrosine kinases (PTKs) -the SRC-family kinase LYN, SYK and the TEC-family kinase BTK- are activated. Phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma 2 (PLC-gamma 2) are important downstream effectors of BCR signalling. This signalling ultimately results in the expression of immediate early genes that further activate the expression of other genes involved in B cell proliferation, differentiation and Ig production as well as other processes.
Class
Organismal Systems; Immune system
Pathway map
hsa04662  B cell receptor signaling pathway
hsa04662

Network
  Element
N00487  BCR-PLCG-Calcineurin signaling pathway
N01695  BCR-BCAP/CD19-PI3K signaling pathway
Drug
D03066  Bectumomab (USAN/INN)
D04036  Epratuzumab (USAN/INN)
D06348  Yttrium Y 90 epratuzumab (USAN)
D06349  Yttrium Y 90 epratuzumab tetraxetan (USAN)
D08933  Inotuzumab ozogamicin (USAN/INN)
D09325  Blinatumomab (USAN/INN)
D09347  Fostamatinib (USAN)
D09348  Fostamatinib disodium (USAN)
D09932  Moxetumomab pasudotox (USAN/INN)
D10223  Ibrutinib (JAN/USAN)
D10560  Idelalisib (JAN/USAN/INN)
D10730  Spebrutinib (USAN/INN)
D10731  Spebrutinib besylate (USAN)
D10761  Polatuzumab vedotin (USAN)
D10893  Acalabrutinib (JAN/USAN/INN)
D11070  Tirabrutinib hydrochloride (JAN/USAN)
D11144  Axicabtagene ciloleucel (USAN)
D11231  Denintuzumab (USAN/INN)
D11232  Denintuzumab mafodotin (USAN/INN)
D11322  Umbralisib (USAN/INN)
D11323  Umbralisib tosylate (USAN)
D11339  Valziflocept (USAN)
D11372  Duvortuxizumab (USAN)
D11386  Tisagenlecleucel-T (USAN)
D11422  Zanubrutinib (JAN/USAN/INN)
D11428  Vecabrutinib (USAN/INN)
D11437  Parsaclisib (USAN/INN)
D11457  Fenebrutinib (USAN/INN)
D11478  Branebrutinib (USAN)
D11496  Obexelimab (USAN/INN)
D11502  Vecabrutinib succinate (USAN)
D11506  Parsaclisib hydrochloride (JAN/USAN)
D11601  Tafasitamab (USAN/INN)
D11720  Acalabrutinib maleate (USAN)
D11757  Inebilizumab (USAN/INN)
D11778  Daxdilimab (USAN)
D11789  Mivavotinib (USAN/INN)
D11790  Mivavotinib citrate (USAN)
D11873  Rilzabrutinib (JAN/USAN/INN)
D11880  Brexucabtagene autoleucel (USAN)
D11942  Inavolisib (USAN/INN)
D11990  Lisocabtagene maraleucel (USAN/INN)
D12050  Pirtobrutinib (JAN/USAN)
D12052  Luxeptinib (USAN)
D12158  Elsubrutinib (USAN/INN)
D12160  Orelabrutinib (USAN/INN)
D12213  Tolebrutinib (JAN/USAN/INN)
D12285  Remibrutinib (JAN/USAN/INN)
D12383  Edralbrutinib (USAN/INN)
D12467  Evobrutinib (USAN/INN)
D12489  Atuzabrutinib (USAN/INN)
D12504  Nemtabrutinib (USAN/INN)
D12594  Tirabrutinib (USAN/INN)
D12704  Acalabrutinib maleate hydrate (JAN)
D12775  Polzastobart (USAN/INN)
D12858  Zelebrudomide (USAN)
Other DBs
GO: 0050853
Organism
Homo sapiens (human) [GN:hsa]
Gene
102723407  IGH; immunoglobulin heavy variable 4-38-2-like [KO:K06856]
973  CD79A; CD79a molecule [KO:K06506]
974  CD79B; CD79b molecule [KO:K06507]
4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]
27071  DAPP1; dual adaptor of phosphotyrosine and 3-phosphoinositides 1 [KO:K12229]
29760  BLNK; B cell linker [KO:K07371]
10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
5879  RAC1; Rac family small GTPase 1 [KO:K04392]
5880  RAC2; Rac family small GTPase 2 [KO:K07860]
5881  RAC3; Rac family small GTPase 3 [KO:K07861]
55024  BANK1; B cell scaffold protein with ankyrin repeats 1 [KO:K26239]
640  BLK; BLK proto-oncogene, Src family tyrosine kinase [KO:K08890] [EC:2.7.10.2]
5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]
4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]
2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]
3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
84433  CARD11; caspase recruitment domain family member 11 [KO:K07367]
8915  BCL10; BCL10 immune signaling adaptor [KO:K07368]
10892  MALT1; MALT1 paracaspase [KO:K07369] [EC:3.4.22.-]
1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
4793  NFKBIB; NFKB inhibitor beta [KO:K02581]
4794  NFKBIE; NFKB inhibitor epsilon [KO:K05872]
8519  IFITM1; interferon induced transmembrane protein 1 [KO:K19831]
975  CD81; CD81 molecule [KO:K06508]
930  CD19; CD19 molecule [KO:K06465]
1380  CR2; complement C3d receptor 2 [KO:K04012]
5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
2213  FCGR2B; Fc gamma receptor IIb [KO:K12560]
3635  INPP5D; inositol polyphosphate-5-phosphatase D [KO:K03084] [EC:3.1.3.86]
3636  INPPL1; inositol polyphosphate phosphatase like 1 [KO:K15909] [EC:3.1.3.86]
10288  LILRB2; leukocyte immunoglobulin like receptor B2 [KO:K06512]
10859  LILRB1; leukocyte immunoglobulin like receptor B1 [KO:K06512]
10990  LILRB5; leukocyte immunoglobulin like receptor B5 [KO:K06512]
11006  LILRB4; leukocyte immunoglobulin like receptor B4 [KO:K06512]
11024  LILRA1; leukocyte immunoglobulin like receptor A1 [KO:K06512]
11025  LILRB3; leukocyte immunoglobulin like receptor B3 [KO:K06512]
11026  LILRA3; leukocyte immunoglobulin like receptor A3 [KO:K06512]
11027  LILRA2; leukocyte immunoglobulin like receptor A2 [KO:K06512]
23547  LILRA4; leukocyte immunoglobulin like receptor A4 [KO:K06512]
79168  LILRA6; leukocyte immunoglobulin like receptor A6 [KO:K06512]
353514  LILRA5; leukocyte immunoglobulin like receptor A5 [KO:K06512]
102725035  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
107987425  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
107987462  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
112268336  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
112268337  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
112268340  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
107987441  leukocyte immunoglobulin-like receptor subfamily B member 3 [KO:K06512]
933  CD22; CD22 molecule [KO:K06467]
971  CD72; CD72 molecule [KO:K06504]
5777  PTPN6; protein tyrosine phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
118788  PIK3AP1; phosphoinositide-3-kinase adaptor protein 1 [KO:K12230]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
PMID:12461567
  Authors
Niiro H, Clark EA.
  Title
Regulation of B-cell fate by antigen-receptor signals.
  Journal
Nat Rev Immunol 2:945-56 (2002)
DOI:10.1038/nri955
Reference
PMID:10358768
  Authors
Kurosaki T.
  Title
Genetic analysis of B cell antigen receptor signaling.
  Journal
Annu Rev Immunol 17:555-92 (1999)
DOI:10.1146/annurev.immunol.17.1.555
Reference
PMID:15886119
  Authors
Nitschke L.
  Title
The role of CD22 and other inhibitory co-receptors in B-cell activation.
  Journal
Curr Opin Immunol 17:290-7 (2005)
DOI:10.1016/j.coi.2005.03.005
Reference
PMID:15752555
  Authors
Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM.
  Title
Complement: central to innate immunity and bridging to adaptive responses.
  Journal
Immunol Lett 97:171-9 (2005)
DOI:10.1016/j.imlet.2004.11.010
Reference
PMID:12033741
  Authors
Kurosaki T.
  Title
Regulation of B-cell signal transduction by adaptor proteins.
  Journal
Nat Rev Immunol 2:354-63 (2002)
DOI:10.1038/nri801
Reference
PMID:15364057
  Authors
Nitschke L, Tsubata T.
  Title
Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
  Journal
Trends Immunol 25:543-50 (2004)
DOI:10.1016/j.it.2004.08.002
Reference
PMID:15771577
  Authors
Jumaa H, Hendriks RW, Reth M.
  Title
B cell signaling and tumorigenesis.
  Journal
Annu Rev Immunol 23:415-45 (2005)
DOI:10.1146/annurev.immunol.23.021704.115606
Reference
PMID:15886112
  Authors
Rickert RC.
  Title
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
  Journal
Curr Opin Immunol 17:237-43 (2005)
DOI:10.1016/j.coi.2005.03.001
Reference
PMID:15457440
  Authors
Zouali M, Sarmay G
  Title
B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
  Journal
Arthritis Rheum 50:2730-41 (2004)
DOI:10.1002/art.20487
Reference
PMID:15322145
  Authors
Chiles TC.
  Title
Regulation and function of cyclin D2 in B lymphocyte subsets.
  Journal
J Immunol 173:2901-7 (2004)
DOI:10.4049/jimmunol.173.5.2901
Reference
PMID:15626471
  Authors
Allam A, Marshall AJ
  Title
Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation.
  Journal
Immunol Lett 97:7-17 (2005)
DOI:10.1016/j.imlet.2004.09.019
Reference
PMID:12119152
  Authors
Gold MR
  Title
To make antibodies or not: signaling by the B-cell antigen receptor.
  Journal
Trends Pharmacol Sci 23:316-24 (2002)
DOI:10.1016/S0165-6147(02)02045-X
Reference
PMID:9697839
  Authors
Fu C, Turck CW, Kurosaki T, Chan AC
  Title
BLNK: a central linker protein in B cell activation.
  Journal
Immunity 9:93-103 (1998)
DOI:10.1016/S1074-7613(00)80591-9
Reference
PMID:11163197
  Authors
Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T
  Title
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.
  Journal
Immunity 13:817-27 (2000)
DOI:10.1016/S1074-7613(00)00079-0
Reference
PMID:18086859
  Authors
Shinohara H, Maeda S, Watarai H, Kurosaki T
  Title
IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.
  Journal
J Exp Med 204:3285-93 (2007)
DOI:10.1084/jem.20070379
Related
pathway
hsa04010  MAPK signaling pathway
hsa04020  Calcium signaling pathway
hsa04064  NF-kappa B signaling pathway
hsa04120  Ubiquitin mediated proteolysis
hsa04151  PI3K-Akt signaling pathway
hsa04610  Complement and coagulation cascades
hsa04810  Regulation of actin cytoskeleton
KO pathway
ko04662   

  All links  
Network (2)   
   KEGG NETWORK (2)   
Genome (1)   
   KEGG GENOME (1)   
Gene (90)   
   KEGG GENES (90)   
All databases (93)   

Download RDF
DBGET integrated database retrieval system